Showing results (311-320 of 380) with videos related to

Sort By:
Pageof 38
Molecular Biology of the Cell|August 28, 2004
Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotypeJoanna Fombonne, Stéphanie Reix, Ramahefarizo Rasolonjanahary, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Resistance to bromocriptine in prolactinomasI Pellegrini, R Rasolonjanahary, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2014
McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patientVladimir Vasilev, Adrian F Daly, Albert Thiry, et al.
Hormone Research|January 1, 1989
Somatostatin receptors in brain and pituitaryJ Epelbaum, F Agid, Y Agid, et al.
Pituitary|December 7, 2010
Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiencyHelena Filipsson Nyström, Alexandru Saveanu, Edna J L Barbosa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Expression of the members of the Ptx family of transcription factors in human pituitary adenomasI Pellegrini-Bouiller, C Manrique, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
Molecular Ecology Resources|February 10, 2016
cloncase: Estimation of sex frequency and effective population size by clonemate resampling in partially clonal organismsSajid Ali, Samuel Soubeyrand, Pierre Gladieux, et al.
Plos One|December 24, 2015
Escherichia coli under Ionic Silver Stress: An Integrative Approach to Explore Transcriptional, Physiological and Biochemical ResponsesClaire Saulou-Bérion, Ignacio Gonzalez, Brice Enjalbert, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2014
Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogsYves Mear, Marie-Pierre Blanchard, Céline Defilles, et al.
Pageof 38